More on CMND

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (12/15/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Clearmind Medicine (NQ:CMND)
Delayed: 1.45 -0.17 (10.49%)
Prev. Close $1.62  
Open$1.56 
52 Wk High$ 
52 Wk Low$ 
Day High$1.56 
Day Low$1.43 
P/E N/A  
EPS$ 
Volume310,780 

Friends, Peers and Foes (?): CWY0, SPRC, PLRZ, CMND.CN, NTLX (more...)

Jul 28, 2026 07:47 AM Clearmind completes Part A of Phase I/II trial for alcohol disorder drug
Jul 28, 2026 07:47 AM Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
Jul 20, 2026 04:00 PM Form 6-K Clearmind Medicine Inc. For: Jul 20
Jul 20, 2026 07:55 AM Clearmind Medicine files Hong Kong patent for PTSD compounds
Jul 20, 2026 07:55 AM Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
Jul 17, 2026 04:02 PM Form 6-K Clearmind Medicine Inc. For: Jul 17
Jul 17, 2026 07:32 AM FDA issues psychedelic therapy guidance as Clearmind notes federal push
Jul 17, 2026 07:32 AM Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
Jul 16, 2026 01:39 PM Form 6-K Clearmind Medicine Inc. For: Jul 16
Jul 16, 2026 09:30 AM Clearmind reports improved nasal retention for its MEAI drug formulation
View All Articles

Entities mentioned with CMND

View All Entities